BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / Felix Baker / Julian Baker
InsiderDirector, 10% Owner
Trades at: ACAD
Net shares · 90d
+2.2M
2.3M buy · 5.5K sell
Net value · 90d
$9.9M
$10.0M in · $131.0K out
Sentiment · 90d
Net buying
99% buying · 1% selling
Open-market trades · 90d
4
2.3M buy · 5.5K sell
Net buy / sell volume (all companies)
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
Show open-market only-
ACAD Grant·A
Director
$0
1.5K sh
Own New
-
ACAD Grant·A
Director
$0
908 sh
Own +0%
-
ACAD Grant·A
Director
$0
19.0K sh
Own +13%
-
ACAD Grant·A
Director, 10% Owner
$0
38.0K sh
Own New
-
ACAD Grant·A
Director, 10% Owner
$0
6.1K sh
Own New
-
ACAD Grant·A
Director, 10% Owner
$0
1.6K sh
Own +0%
-
ACAD Grant·A
Director
$0
19.2K sh
Own New
-
ACAD Grant·A
Director
$0
6.4K sh
Own +2%
-
ACAD Grant·A
Director, 10% Owner
$0
32.0K sh
Own New
-
ACAD Grant·A
Director, 10% Owner
$0
18.6K sh
Own +1%
-
ACAD Grant·A
Director
$0
36.5K sh
Own New
-
ACAD Grant·A
Director
$0
6.1K sh
Own +4%
-
ACAD Sell·S
Director
$65.6K
2.8K sh · $23.79
Own -2%
-
ACAD Sell·S
Director
$65.4K
2.7K sh · $23.85
Own -2%
-
ACAD Grant·A
Director
$0
67.0K sh
Own New
-
ACAD Exercise·M
Director, 10% Owner
$0
15.0K sh
Own New
-
ACAD Exercise·M
Director, 10% Owner
$1.3M
15.0K sh · $84.53
Own +1%
-
ACAD Buy·P
Director, 10% Owner
$9.5M
2.1M sh · $4.44
Own +12%
-
ACAD Buy·P
Director, 10% Owner
$508.8K
114.6K sh · $4.44
Own +7%
-
ACAD Grant·A
Director, 10% Owner
$0
421 sh
Own +0%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | ACAD | Grant A | 1.5K | $0 |
| Jun 17, 2026 | ACAD | Grant A | 908 | $0 |
| Jun 11, 2026 | ACAD | Grant A | 19.0K | $0 |
| Jun 9, 2026 | ACAD | Grant A | 38.0K | $0 |
| Jun 8, 2026 | ACAD | Grant A | 6.1K | $0 |
| Jun 8, 2026 | ACAD | Grant A | 1.6K | $0 |
| Jun 3, 2026 | ACAD | Grant A | 19.2K | $0 |
| Jun 3, 2026 | ACAD | Grant A | 6.4K | $0 |
| May 29, 2026 | ACAD | Grant A | 32.0K | $0 |
| May 29, 2026 | ACAD | Grant A | 18.6K | $0 |
| May 29, 2026 | ACAD | Grant A | 36.5K | $0 |
| May 29, 2026 | ACAD | Grant A | 6.1K | $0 |
| May 22, 2026 | ACAD | Sell S | 2.8K | $65.6K |
| May 22, 2026 | ACAD | Sell S | 2.7K | $65.4K |
| May 20, 2026 | ACAD | Grant A | 67.0K | $0 |
| May 8, 2026 | ACAD | Exercise M | 15.0K | $0 |
| May 8, 2026 | ACAD | Exercise M | 15.0K | $1.3M |
| Apr 21, 2026 | ACAD | Buy P | 2.1M | $9.5M |
| Apr 21, 2026 | ACAD | Buy P | 114.6K | $508.8K |
| Mar 31, 2026 | ACAD | Grant A | 421 | $0 |
About BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / Felix Baker / Julian Baker
This profile aggregates every SEC Form 4 insider transaction reported by BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / Felix Baker / Julian Baker across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.